WTSIi018-B-16

General

Cell Line

hPSCreg name WTSIi018-B-16
Cite as:
WTSIi018-B-16 (RRID:CVCL_D6KU)
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
WTSIi018-B
(HPSI0114i-kolf_2)
WTSIi018-B-21
(Kolf 2.1 J (TARDBP M337V SNV/SNV))
WTSIi018-B-1
(HPSI0114i-kolf_2-C1)
WTSIi018-B-22
(Kolf 2.1 J (TARDBP Q331K WT/SNV))
WTSIi018-B-23
(Kolf 2.1 J (TARDBP Q331K SNV/SNV))
WTSIi018-B-24
(Kolf 2.1 J (FUS R495X WT/SNV))
WTSIi018-B-25
(Kolf 2.1 J (FUS R495X SNV/SNV))
WTSIi018-B-26
(Kolf 2.1 J (FUS R521H WT/SNV))
WTSIi018-B-27
(Kolf 2.1 J (FUS R521H SNV/SNV))
WTSIi018-B-18
(Kolf 2.1 J (TARDBP M337V WT/SNV))
WTSIi018-A
(HPSI0114i-kolf_3)
Last update 18th December 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Paul-Ehrlich-Institut (PEI)

External Databases

BioSamples SAMEA115039275
Cellosaurus CVCL_D6KU
Wikidata Q127384720

General Information

Publications
* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity White - White British

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
Yes

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA2398402
HipSci HPSI-kolf

Ethics

Also have a look at the ethics information for the parental line WTSIi018-B .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line WTSIi018-B.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Other medium:
Base medium: StemFlex™ Basal Medium
Main protein source:
Serum concentration: %
Supplements
StemFlex™ Supplement 10X 50 ml

Characterisation

No characterisation data could be found for this subclone. Please open parental cell line WTSIi018-B .

Genotyping

Karyotyping (Cell Line)

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • Ataxia Telangiectasia
  • Louis-Bar Syndrome
  • ataxia-telangiectasia
  • Ataxia Telangiectasia Syndrome
  • Ataxia-telangiectasia
  • Ataxia-Telangiectasia Syndrome
show more synonyms
Genetic modifications
ATM (target)
Isogenic modification
11q22.3
NM_000051.4(ATM):c.9161C>T (p.Ala3054Val)
Homozygous
Homozygous point mutation C->T in exon 63 at A3054 in the ATM gene. Introduction of A3054V. Cell line was generated by using CRISPR/Cas-mediated Homology-directed Repair.
Mutated